PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 168 filers reported holding PTC THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,007,000 | +30.6% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $771,000 | -54.8% | 16,500 | -50.9% | 0.00% | 0.0% |
| Q2 2020 | $1,704,000 | +48.7% | 33,600 | -51.1% | 0.00% | -40.0% |
| Q4 2017 | $1,146,000 | -57.1% | 68,700 | -48.5% | 0.01% | -54.5% |
| Q3 2017 | $2,669,000 | -9.9% | 133,400 | -17.5% | 0.01% | -15.4% |
| Q2 2017 | $2,962,000 | +2775.7% | 161,600 | +1439.0% | 0.01% | – |
| Q1 2017 | $103,000 | -94.5% | 10,500 | -84.9% | 0.00% | -100.0% |
| Q3 2015 | $1,858,000 | -45.7% | 69,581 | -2.1% | 0.01% | -42.9% |
| Q2 2015 | $3,420,000 | -20.9% | 71,053 | 0.0% | 0.01% | -22.2% |
| Q1 2015 | $4,324,000 | +26.5% | 71,053 | +7.6% | 0.02% | +28.6% |
| Q4 2014 | $3,419,000 | +25.7% | 66,036 | +6.8% | 0.01% | +16.7% |
| Q3 2014 | $2,720,000 | +68.3% | 61,810 | 0.0% | 0.01% | +71.4% |
| Q2 2014 | $1,616,000 | – | 61,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |